Login / Signup
Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma In Vitro and In Vivo .
Prin Sungwan
Sonexai Kidoikhammouan
Unchalee Thonsri
Charupong Saengboonmee
Sopit Wongkham
Seiji Okada
Wunchana Seubwai
Published in:
In vivo (Athens, Greece) (2024)
Dinaciclib has the potential to be an effective therapeutic agent to control tumor cell growth of both parental and gemcitabine-resistant CCA cells.
Keyphrases
</>
induced apoptosis
oxidative stress
squamous cell carcinoma
locally advanced
radiation therapy
human health
cell proliferation
climate change